Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Baylor1965on Apr 23, 2011 10:15am
434 Views
Post# 18477025

RE: RE: RE: RE: RE: RE: RE: RE: News but Not Reall

RE: RE: RE: RE: RE: RE: RE: RE: News but Not ReallLike I said, I spoke to SCT many times and they are quite open to disclosing where they are at. They don't say anything that is material but they do give you the inner working and details of the industry and that is of great help in piecing the puzzle. For example, they were straight up with the partner situation and the plan design study that is currently going on.....I recommend you do the same. But nobody is holding you in a headlock.....if you're that worried that this is the end,  take  the 8.5 cents on the table and you'll look like a genius if they do go belly up....like I said in my previous post, it takes a long time in this industry to find success with lots of ups and downs.... your nerves are quite normal.In my opinion I feel exactly the same way I did when I picked up 1000 shares of aapl in 2002 at 7.92 cents and reaped the benefits. I don't expect anyone else to feel this way about this company. I post on here to gather and share info with investors who feel the same way I do about SCT and their patents. 
Bullboard Posts